Topical formulation containing combination with montelukast and mussel adhesive protein

摘要

Includes a pharmaceutically acceptable salt of Montelukast or a solvate thereof, (a) at least one mussel adhesion protein or derivative thereof, and (b) Montelukast or a pharmaceutically acceptable salt or solvate thereof. , Combined products, and pharmaceutical formulations are provided. Formulations and combination products are particularly useful for direct topical administration for the treatment of inflammation, inflammatory disorders, and / or conditions characterized by inflammation, including wounds, burns, psoriasis, acne, and atopic dermatitis. .. [Selection diagram] None